Methylprednisolone aceponate: Difference between revisions
Appearance
Content deleted Content added
m Removed Category:Acetates; Adding category Category:Acetate esters (using HotCat) |
|||
(26 intermediate revisions by 15 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{drugbox | |
|||
{{Drugbox |
|||
| Verifiedfields = changed |
|||
| Watchedfields = changed |
|||
| verifiedrevid = 387713856 |
|||
| IUPAC_name = |
| IUPAC_name = |
||
| image = Methylprednisolone aceponate.svg |
| image = Methylprednisolone aceponate.svg |
||
| width = 250px |
|||
⚫ | |||
⚫ | |||
<!--Clinical data--> |
|||
⚫ | |||
| tradename = Advantan, Avancort |
|||
| PubChem = 63019 |
|||
| Drugs.com = {{drugs.com|CDI|methylprednisolone_aceponate}} |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| molecular_weight = 472.571 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| legal_status = |
|||
⚫ | |||
<!--Pharmacokinetic data--> |
|||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
Line 14: | Line 26: | ||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
⚫ | |||
<!--Identifiers--> |
|||
⚫ | |||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| |
| PubChem = 63019 |
||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
⚫ | |||
⚫ | |||
| UNII_Ref = {{fdacite|changed|FDA}} |
|||
| UNII = ET54W9J4U2 |
|||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = 56717 |
|||
| ChEBI = 135762 |
|||
| ChEMBL = 1697782 |
|||
| synonyms = Methylprednisolone 17α-propionate 21-acetate; ZK-91588 |
|||
<!--Chemical data--> |
|||
⚫ | |||
| SMILES = CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2C[C@@H](C4=CC(=O)C=C[C@]34C)C)O)C)C(=O)COC(=O)C |
|||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C27H36O7/c1-6-23(32)34-27(22(31)14-33-16(3)28)10-8-19-18-11-15(2)20-12-17(29)7-9-25(20,4)24(18)21(30)13-26(19,27)5/h7,9,12,15,18-19,21,24,30H,6,8,10-11,13-14H2,1-5H3/t15-,18-,19-,21-,24+,25-,26-,27-/m0/s1 |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChIKey = DALKLAYLIPSCQL-YPYQNWSCSA-N |
|||
}} |
}} |
||
'''Methylprednisolone aceponate''' is a [[glucocorticosteroid]].<ref name="pmid17298428">{{cite journal |author=Bieber T, Vick K, Fölster-Holst R, ''et al.'' |title=Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis |journal=Allergy |volume=62 |issue=2 |pages=184–9 |year=2007 |month=February |pmid=17298428 |doi=10.1111/j.1398-9995.2006.01269.x |url=http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0105-4538&date=2007&volume=62&issue=2&spage=184}}</ref> |
|||
'''Methylprednisolone aceponate''', or '''methylprednisolone acetate propionate''', sold under the brand names '''Advantan''' and '''Avancort''', is a [[glucocorticoid]] and a [[corticosteroid ester]]—specifically the C17α [[propionate]] and C21 [[acetate]] [[ester|diester]] of [[methylprednisolone]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA811|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=811–}}</ref><ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA675|year=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=675–}}</ref><ref name="pmid17298428">{{cite journal |vauthors=Bieber T, Vick K, Fölster-Holst R, etal |title=Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis |journal=Allergy |volume=62 |issue=2 |pages=184–9 |date=February 2007 |pmid=17298428 |doi=10.1111/j.1398-9995.2006.01269.x |s2cid=41761398 }}</ref> |
|||
In [[Russia]] and some other countries the drug is available in 4 dosage forms differing in consistency and water content: [[emulsion]] (or [[lotion]]), cream, ointment and fatty ointment.<ref>{{cite web |title=Advantan (methylprednisolone aceponate) Full Prescribing Information Lists |url=https://grls.rosminzdrav.ru/GRLS.aspx?RegNumber=&MnnR=&lf=&TradeNmR=адвантан&OwnerName=&MnfOrg=&MnfOrgCountry=&isfs=0®type=1%2c6&pageSize=10&order=Registered&orderType=desc&pageNum=1 |website=State Register of Medicines |access-date=31 March 2023 |language=Russian}}</ref> |
|||
==Synthesis== |
|||
[[File:Methylprednisolone Aceponate synthesis.svg|thumb|center|500px|[https://www.chemdrug.com/article/8/3284/16419980.html ChemDrug] Synthesis:<ref>Prous, J.; Castaer, J.; Methylprednisolone Aceponate. Drugs Fut 1993, 18, 2, 130.</ref><ref>Sugai, S., Okazaki, T., Kajiwara, Y., Kanbara, T., Naito, Y., Yoshida, S., Akaboshi, S., Ikegami, S., Kamano, Y. (1985). "Studies on topical antiinflammatory corticosteroids. I. Syntheses and vasoconstrictive activities of 11.BETA.,17.ALPHA.,21-trihydroxy-6.ALPHA.-methyl-1,4-pregnadiene-3,20-dione 17-ester and 17,21-diester derivatives". Chemical and Pharmaceutical Bulletin. 33 (5): 1889–1898. doi:10.1248/cpb.33.1889.</ref> Patent:<ref>Klaus Annen, et al. {{US patent|4587236}} (1986 to Bayer Pharma AG).</ref>]] |
|||
*methylprednisolone [83-43-2] (1) |
|||
*Triethyl orthopropionate [115-80-0] (2) |
|||
*[https://pubchem.ncbi.nlm.nih.gov/compound/13131717 PC13131717] (3) |
|||
*[79512-61-1] (4) |
|||
==See also== |
==See also== |
||
* [[List of corticosteroid esters#Methylprednisolone esters|List of corticosteroid esters § Methylprednisolone esters]] |
|||
* [[Methylprednisolone]] |
|||
==References== |
==References== |
||
{{Reflist}} |
{{Reflist}} |
||
⚫ | |||
{{Glucocorticoids and antiglucocorticoids}} |
|||
{{Glucocorticoid receptor modulators}} |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
{{treatment-stub}} |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ |